Android app on Google Play

Sinovac Biotech, Ltd (SVA) Misses Q3 EPS by 3c

November 15, 2012 8:23 AM EST Send to a Friend
Sinovac Biotech, Ltd (NASDAQ: SVA) reported Q3 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $12.35 million.

For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment